Bio Protocol vs QuarkChain — how do they compare? Bio Protocol trades at Rp439.17 (market cap Rp996,26M, Rp160,17M 24h volume), while QuarkChain trades at Rp35.89 (market cap Rp259,67M, Rp56,49M 24h volume). The key difference: Bio Protocol is far larger — about 3.8× QuarkChain's market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while QuarkChain's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and QuarkChain for 34 Days on average.
| BIO | QKC | |
|---|---|---|
Market Cap | Rp996,26M | Rp259,67M |
Volume (24h) | Rp160,17M | Rp56,49M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 7,3B QKC |
Typical Hold Time | 18 Days | 34 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
QuarkChain (QKC) trades at Rp36.237 with a market cap of Rp265.3M, showing bearish technical signals from moving averages while oscillators remain neutral. The token faces resistance at Rp36 with support at Rp35 levels. Average hold time of 34 days indicates moderate holding patterns among investors.
Overall outlook remains cautious with technical indicators favoring selling pressure. Key opportunities include potential bounce from support levels, while risks involve low market cap vulnerability and limited trading volume. No major protocol updates or ecosystem developments were noted recently.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The QuarkChain Network is a permissionless blockchain architecture that aims to meet global commercial standards. It aims to provide a secure, decentralized, and scalable blockchain solution to deliver 100,000+ on-chain TPS.
Read more on QKC →